Anaptysbio (ANAB) Leases: 2019-2025
Historic Leases for Anaptysbio (ANAB) over the last 7 years, with Sep 2025 value amounting to $13.0 million.
- Anaptysbio's Leases fell 12.43% to $13.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.0 million, marking a year-over-year decrease of 12.43%. This contributed to the annual value of $14.4 million for FY2024, which is 11.07% down from last year.
- Anaptysbio's Leases amounted to $13.0 million in Q3 2025, which was down 3.49% from $13.5 million recorded in Q2 2025.
- In the past 5 years, Anaptysbio's Leases registered a high of $20.3 million during Q2 2021, and its lowest value of $218,000 during Q1 2021.
- Its 3-year average for Leases is $15.3 million, with a median of $15.3 million in 2024.
- Per our database at Business Quant, Anaptysbio's Leases tumbled by 82.03% in 2021 and then soared by 8,683.03% in 2022.
- Quarterly analysis of 5 years shows Anaptysbio's Leases stood at $19.6 million in 2021, then declined by 8.49% to $17.9 million in 2022, then dropped by 9.63% to $16.2 million in 2023, then dropped by 11.07% to $14.4 million in 2024, then decreased by 12.43% to $13.0 million in 2025.
- Its Leases stands at $13.0 million for Q3 2025, versus $13.5 million for Q2 2025 and $13.9 million for Q1 2025.